Training and Education About Substance Use Treatment

Provides guidance on the use of buprenorphine among a number of topics, including physiology and pharmacology of opioids, opioid addiction, and buprenorphine treatment; screening and assessment of OUDs; protocols for buprenorphine treatment; management of special populations; and policies and procedures related to DATA 2000.

Provides guidelines related to opioid dependence that aim to: reduce global barriers to effective treatment; contribute to the development of evidence-based, ethical treatment policies; contribute to improvement of the quality of pharmacological treatment; and facilitate implementation of effective treatment policies and programs.

Provides information on evidence-based treatment of OUD. This guideline is the only document of its kind to include all Food and Drug Administration (FDA)-approved medications in one place.

Provides an overview of the key points of the National Practice Guideline, detailed recommendations for OUD diagnosis, and information on treatment settings and opioid withdrawal. Describes MAT options and considerations for treating special populations. Links to additional resources, such as a pocket guide and a slide deck.

Offers guidance on the use of MAT with extended-release injectable naltrexone for the treatment of OUD. Covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.

Describes what physicians need to know about the patient limit of 275, such as eligibility and credentials.

Provides a high-level overview of the potential for buprenorphine abuse and how to reduce the risks.

Provides an overview of the steps people dependent on opioids need to take when they seek treatment for the first time.

Offers resources to find buprenorphine treatment.

Provides information for patients on how to locate a physician certified to provide buprenorphine treatment.